nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—PTGS2—systemic lupus erythematosus	0.228	0.529	CbGaD
Bismuth Subsalicylate—ALB—systemic lupus erythematosus	0.203	0.471	CbGaD
Bismuth Subsalicylate—PTGS2—Dapsone—systemic lupus erythematosus	0.0753	0.196	CbGbCtD
Bismuth Subsalicylate—PTGS2—Triamcinolone—systemic lupus erythematosus	0.0653	0.17	CbGbCtD
Bismuth Subsalicylate—PTGS1—Dapsone—systemic lupus erythematosus	0.0636	0.166	CbGbCtD
Bismuth Subsalicylate—PTGS2—Betamethasone—systemic lupus erythematosus	0.056	0.146	CbGbCtD
Bismuth Subsalicylate—ALB—Mycophenolate mofetil—systemic lupus erythematosus	0.0412	0.107	CbGbCtD
Bismuth Subsalicylate—ALB—Prednisone—systemic lupus erythematosus	0.0329	0.0859	CbGbCtD
Bismuth Subsalicylate—PTGS2—Dexamethasone—systemic lupus erythematosus	0.0326	0.085	CbGbCtD
Bismuth Subsalicylate—TF—choroid plexus—systemic lupus erythematosus	0.0303	0.441	CbGeAlD
Bismuth Subsalicylate—ALB—Methotrexate—systemic lupus erythematosus	0.0165	0.0431	CbGbCtD
Bismuth Subsalicylate—TF—urine—systemic lupus erythematosus	0.00811	0.118	CbGeAlD
Bismuth Subsalicylate—TF—blood plasma—systemic lupus erythematosus	0.00423	0.0616	CbGeAlD
Bismuth Subsalicylate—TF—connective tissue—systemic lupus erythematosus	0.00225	0.0328	CbGeAlD
Bismuth Subsalicylate—TF—skin of body—systemic lupus erythematosus	0.00204	0.0296	CbGeAlD
Bismuth Subsalicylate—TF—kidney—systemic lupus erythematosus	0.00192	0.0279	CbGeAlD
Bismuth Subsalicylate—TF—lymphoid tissue—systemic lupus erythematosus	0.00165	0.024	CbGeAlD
Bismuth Subsalicylate—TF—bone marrow—systemic lupus erythematosus	0.0015	0.0219	CbGeAlD
Bismuth Subsalicylate—PTGS1—endothelium—systemic lupus erythematosus	0.00141	0.0206	CbGeAlD
Bismuth Subsalicylate—TF—lung—systemic lupus erythematosus	0.00136	0.0198	CbGeAlD
Bismuth Subsalicylate—PTGS2—endothelium—systemic lupus erythematosus	0.00135	0.0197	CbGeAlD
Bismuth Subsalicylate—TF—nervous system—systemic lupus erythematosus	0.00126	0.0183	CbGeAlD
Bismuth Subsalicylate—PTGS1—blood plasma—systemic lupus erythematosus	0.00126	0.0183	CbGeAlD
Bismuth Subsalicylate—TF—central nervous system—systemic lupus erythematosus	0.00121	0.0177	CbGeAlD
Bismuth Subsalicylate—PTGS2—blood plasma—systemic lupus erythematosus	0.0012	0.0175	CbGeAlD
Bismuth Subsalicylate—PTGS1—connective tissue—systemic lupus erythematosus	0.000668	0.00973	CbGeAlD
Bismuth Subsalicylate—PTGS2—connective tissue—systemic lupus erythematosus	0.000639	0.0093	CbGeAlD
Bismuth Subsalicylate—PTGS1—skin of body—systemic lupus erythematosus	0.000604	0.00879	CbGeAlD
Bismuth Subsalicylate—PTGS2—skin of body—systemic lupus erythematosus	0.000577	0.0084	CbGeAlD
Bismuth Subsalicylate—PTGS1—kidney—systemic lupus erythematosus	0.000569	0.00828	CbGeAlD
Bismuth Subsalicylate—PTGS2—kidney—systemic lupus erythematosus	0.000544	0.00792	CbGeAlD
Bismuth Subsalicylate—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.00051	0.159	CbGdCrCtD
Bismuth Subsalicylate—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.000502	0.156	CbGdCrCtD
Bismuth Subsalicylate—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.000502	0.156	CbGdCrCtD
Bismuth Subsalicylate—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.00049	0.153	CbGdCrCtD
Bismuth Subsalicylate—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000467	0.0068	CbGeAlD
Bismuth Subsalicylate—PTGS1—tendon—systemic lupus erythematosus	0.000459	0.00669	CbGeAlD
Bismuth Subsalicylate—PTGS2—tendon—systemic lupus erythematosus	0.000439	0.00639	CbGeAlD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—P2RY12—systemic lupus erythematosus	0.000431	0.0124	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—bone marrow—systemic lupus erythematosus	0.000425	0.00619	CbGeAlD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL1RN—systemic lupus erythematosus	0.000406	0.0117	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—lung—systemic lupus erythematosus	0.000403	0.00587	CbGeAlD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—CSK—systemic lupus erythematosus	0.000396	0.0114	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—lung—systemic lupus erythematosus	0.000385	0.00561	CbGeAlD
Bismuth Subsalicylate—PTGS1—nervous system—systemic lupus erythematosus	0.000373	0.00544	CbGeAlD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—CRP—systemic lupus erythematosus	0.000373	0.0108	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Recycling of bile acids and salts—RXRA—systemic lupus erythematosus	0.000371	0.0107	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	0.000367	0.0106	CbGpPWpGaD
Bismuth Subsalicylate—Hepatitis—Leflunomide—systemic lupus erythematosus	0.000365	0.00462	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—LYN—systemic lupus erythematosus	0.00036	0.0104	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—central nervous system—systemic lupus erythematosus	0.000359	0.00523	CbGeAlD
Bismuth Subsalicylate—PTGS2—nervous system—systemic lupus erythematosus	0.000357	0.0052	CbGeAlD
Bismuth Subsalicylate—Extravasation—Methotrexate—systemic lupus erythematosus	0.000355	0.0045	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Prednisone—systemic lupus erythematosus	0.000354	0.00449	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Leflunomide—systemic lupus erythematosus	0.000345	0.00437	CcSEcCtD
Bismuth Subsalicylate—PTGS2—central nervous system—systemic lupus erythematosus	0.000344	0.005	CbGeAlD
Bismuth Subsalicylate—Asthma—Mycophenolate mofetil—systemic lupus erythematosus	0.000343	0.00435	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Prednisone—systemic lupus erythematosus	0.000339	0.00429	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Cyclosporine—systemic lupus erythematosus	0.000337	0.00427	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Prednisone—systemic lupus erythematosus	0.000335	0.00425	CcSEcCtD
Bismuth Subsalicylate—TF—Differentiation Pathway—VEGFA—systemic lupus erythematosus	0.000331	0.00955	CbGpPWpGaD
Bismuth Subsalicylate—Abdominal pain upper—Hydrocortisone—systemic lupus erythematosus	0.00033	0.00419	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUNB—systemic lupus erythematosus	0.000325	0.00939	CbGpPWpGaD
Bismuth Subsalicylate—Weight increased—Cyclosporine—systemic lupus erythematosus	0.00032	0.00406	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—systemic lupus erythematosus	0.000319	0.00922	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—ALB—systemic lupus erythematosus	0.000319	0.00921	CbGpPWpGaD
Bismuth Subsalicylate—Lethargy—Betamethasone—systemic lupus erythematosus	0.000315	0.004	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Dexamethasone—systemic lupus erythematosus	0.000315	0.004	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000312	0.00396	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Leflunomide—systemic lupus erythematosus	0.000311	0.00394	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Dapsone—systemic lupus erythematosus	0.000309	0.00391	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.000308	0.0958	CbGdCrCtD
Bismuth Subsalicylate—Headache—Dapsone—systemic lupus erythematosus	0.000304	0.00385	CcSEcCtD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—ALB—systemic lupus erythematosus	0.000304	0.00878	CbGpPWpGaD
Bismuth Subsalicylate—TF—Differentiation Pathway—TGFB1—systemic lupus erythematosus	0.000304	0.00877	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—systemic lupus erythematosus	0.000303	0.00876	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000303	0.0942	CbGdCrCtD
Bismuth Subsalicylate—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000303	0.0942	CbGdCrCtD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—CRP—systemic lupus erythematosus	0.000296	0.00855	CbGpPWpGaD
Bismuth Subsalicylate—Epistaxis—Cyclosporine—systemic lupus erythematosus	0.000296	0.00375	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Methotrexate—systemic lupus erythematosus	0.000296	0.00375	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.000296	0.0921	CbGdCrCtD
Bismuth Subsalicylate—Asthma—Triamcinolone—systemic lupus erythematosus	0.000294	0.00373	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	0.000292	0.00842	CbGpPWpGaD
Bismuth Subsalicylate—Weight increased—Prednisolone—systemic lupus erythematosus	0.000291	0.00369	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	0.00029	0.00838	CbGpPWpGaD
Bismuth Subsalicylate—Epistaxis—Mycophenolate mofetil—systemic lupus erythematosus	0.000289	0.00366	CcSEcCtD
Bismuth Subsalicylate—Nausea—Dapsone—systemic lupus erythematosus	0.000288	0.00365	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Hydrocortisone—systemic lupus erythematosus	0.000285	0.00361	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Cyclosporine—systemic lupus erythematosus	0.000282	0.00357	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Methotrexate—systemic lupus erythematosus	0.00028	0.00355	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000275	0.00348	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Prednisone—systemic lupus erythematosus	0.000275	0.00348	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Mycophenolate mofetil—systemic lupus erythematosus	0.000273	0.00346	CcSEcCtD
Bismuth Subsalicylate—Infection—Azathioprine—systemic lupus erythematosus	0.000273	0.00346	CcSEcCtD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	0.000271	0.00782	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—RASGRP1—systemic lupus erythematosus	0.00027	0.0078	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	0.000269	0.00775	CbGpPWpGaD
Bismuth Subsalicylate—Weight increased—Triamcinolone—systemic lupus erythematosus	0.000268	0.0034	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Methylprednisolone—systemic lupus erythematosus	0.000267	0.00339	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Cyclosporine—systemic lupus erythematosus	0.000263	0.00333	CcSEcCtD
Bismuth Subsalicylate—Infection—Leflunomide—systemic lupus erythematosus	0.000258	0.00326	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—ITGAX—systemic lupus erythematosus	0.000257	0.00743	CbGpPWpGaD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	0.000256	0.00741	CbGpPWpGaD
Bismuth Subsalicylate—Tinnitus—Mycophenolate mofetil—systemic lupus erythematosus	0.000256	0.00325	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—F3—systemic lupus erythematosus	0.000253	0.00732	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—systemic lupus erythematosus	0.000251	0.00725	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—PTGS2—systemic lupus erythematosus	0.00025	0.00722	CbGpPWpGaD
Bismuth Subsalicylate—Hallucination—Hydrocortisone—systemic lupus erythematosus	0.000249	0.00316	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Triamcinolone—systemic lupus erythematosus	0.000248	0.00314	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Leflunomide—systemic lupus erythematosus	0.000247	0.00313	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—systemic lupus erythematosus	0.000244	0.00705	CbGpPWpGaD
Bismuth Subsalicylate—Weight increased—Betamethasone—systemic lupus erythematosus	0.000243	0.00308	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Dexamethasone—systemic lupus erythematosus	0.000243	0.00308	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Cyclosporine—systemic lupus erythematosus	0.00024	0.00304	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Mycophenolate mofetil—systemic lupus erythematosus	0.000234	0.00297	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Methylprednisolone—systemic lupus erythematosus	0.000234	0.00297	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—systemic lupus erythematosus	0.000233	0.00674	CbGpPWpGaD
Bismuth Subsalicylate—Lethargy—Methotrexate—systemic lupus erythematosus	0.00023	0.00291	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—CLU—systemic lupus erythematosus	0.000229	0.00662	CbGpPWpGaD
Bismuth Subsalicylate—TF—Differentiation Pathway—IL6—systemic lupus erythematosus	0.000229	0.00661	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Leflunomide—systemic lupus erythematosus	0.000228	0.00289	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Azathioprine—systemic lupus erythematosus	0.000226	0.00287	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Leflunomide—systemic lupus erythematosus	0.000225	0.00286	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—systemic lupus erythematosus	0.000224	0.00646	CbGpPWpGaD
Bismuth Subsalicylate—Erythema—Prednisolone—systemic lupus erythematosus	0.000223	0.00283	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—P2RY12—systemic lupus erythematosus	0.000222	0.00641	CbGpPWpGaD
Bismuth Subsalicylate—Pain—Leflunomide—systemic lupus erythematosus	0.000222	0.00281	CcSEcCtD
Bismuth Subsalicylate—Constipation—Leflunomide—systemic lupus erythematosus	0.000222	0.00281	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet degranulation—VEGFA—systemic lupus erythematosus	0.00022	0.00635	CbGpPWpGaD
Bismuth Subsalicylate—Erythema—Hydrocortisone—systemic lupus erythematosus	0.000218	0.00276	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Azathioprine—systemic lupus erythematosus	0.000217	0.00275	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Leflunomide—systemic lupus erythematosus	0.000214	0.00271	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Betamethasone—systemic lupus erythematosus	0.000213	0.0027	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Dexamethasone—systemic lupus erythematosus	0.000213	0.0027	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Prednisone—systemic lupus erythematosus	0.000212	0.00268	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUNB—systemic lupus erythematosus	0.00021	0.00607	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—JAK1—systemic lupus erythematosus	0.00021	0.00605	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—VEGFA—systemic lupus erythematosus	0.000209	0.00605	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic lupus erythematosus	0.000209	0.00603	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Eicosanoid Synthesis—PTGS2—systemic lupus erythematosus	0.000207	0.00599	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Leflunomide—systemic lupus erythematosus	0.000206	0.00261	CcSEcCtD
Bismuth Subsalicylate—Erythema—Triamcinolone—systemic lupus erythematosus	0.000205	0.0026	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Leflunomide—systemic lupus erythematosus	0.000205	0.0026	CcSEcCtD
Bismuth Subsalicylate—Erythema—Methylprednisolone—systemic lupus erythematosus	0.000205	0.00259	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—SELE—systemic lupus erythematosus	0.000204	0.0059	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—CSK—systemic lupus erythematosus	0.000204	0.0059	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—TGFB1—systemic lupus erythematosus	0.000202	0.00583	CbGpPWpGaD
Bismuth Subsalicylate—Confusional state—Cyclosporine—systemic lupus erythematosus	0.000202	0.00256	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Triamcinolone—systemic lupus erythematosus	0.000201	0.00255	CcSEcCtD
Bismuth Subsalicylate—Oedema—Cyclosporine—systemic lupus erythematosus	0.0002	0.00254	CcSEcCtD
Bismuth Subsalicylate—Infection—Cyclosporine—systemic lupus erythematosus	0.000199	0.00252	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Mycophenolate mofetil—systemic lupus erythematosus	0.000197	0.00249	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—IL2RA—systemic lupus erythematosus	0.000196	0.00565	CbGpPWpGaD
Bismuth Subsalicylate—Oedema—Mycophenolate mofetil—systemic lupus erythematosus	0.000195	0.00247	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TNFSF13—systemic lupus erythematosus	0.000195	0.00562	CbGpPWpGaD
Bismuth Subsalicylate—Asthma—Methotrexate—systemic lupus erythematosus	0.000194	0.00246	CcSEcCtD
Bismuth Subsalicylate—ALB—Bile acid and bile salt metabolism—RXRA—systemic lupus erythematosus	0.000194	0.0056	CbGpPWpGaD
Bismuth Subsalicylate—Infection—Mycophenolate mofetil—systemic lupus erythematosus	0.000194	0.00246	CcSEcCtD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic lupus erythematosus	0.000192	0.00555	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—ITGAM—systemic lupus erythematosus	0.000192	0.00555	CbGpPWpGaD
Bismuth Subsalicylate—Anorexia—Cyclosporine—systemic lupus erythematosus	0.000191	0.00242	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000188	0.00238	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Methotrexate—systemic lupus erythematosus	0.000186	0.00236	CcSEcCtD
Bismuth Subsalicylate—Erythema—Betamethasone—systemic lupus erythematosus	0.000186	0.00236	CcSEcCtD
Bismuth Subsalicylate—Erythema—Dexamethasone—systemic lupus erythematosus	0.000186	0.00236	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Mycophenolate mofetil—systemic lupus erythematosus	0.000186	0.00236	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—LYN—systemic lupus erythematosus	0.000186	0.00536	CbGpPWpGaD
Bismuth Subsalicylate—Hallucination—Prednisone—systemic lupus erythematosus	0.000185	0.00235	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Leflunomide—systemic lupus erythematosus	0.000183	0.00232	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet degranulation—CLU—systemic lupus erythematosus	0.000183	0.00527	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—SH2B3—systemic lupus erythematosus	0.000182	0.00526	CbGpPWpGaD
Bismuth Subsalicylate—Oedema—Prednisolone—systemic lupus erythematosus	0.000182	0.00231	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Azathioprine—systemic lupus erythematosus	0.000182	0.0023	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—systemic lupus erythematosus	0.000179	0.00518	CbGpPWpGaD
Bismuth Subsalicylate—Somnolence—Cyclosporine—systemic lupus erythematosus	0.000178	0.00225	CcSEcCtD
Bismuth Subsalicylate—Oedema—Hydrocortisone—systemic lupus erythematosus	0.000178	0.00225	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000177	0.00225	CcSEcCtD
Bismuth Subsalicylate—Infection—Hydrocortisone—systemic lupus erythematosus	0.000177	0.00224	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Cyclosporine—systemic lupus erythematosus	0.000176	0.00223	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Azathioprine—systemic lupus erythematosus	0.000175	0.00221	CcSEcCtD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—CLU—systemic lupus erythematosus	0.000174	0.00502	CbGpPWpGaD
Bismuth Subsalicylate—Decreased appetite—Cyclosporine—systemic lupus erythematosus	0.000174	0.0022	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—systemic lupus erythematosus	0.000174	0.00501	CbGpPWpGaD
Bismuth Subsalicylate—Somnolence—Mycophenolate mofetil—systemic lupus erythematosus	0.000174	0.0022	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Methotrexate—systemic lupus erythematosus	0.000173	0.0022	CcSEcCtD
Bismuth Subsalicylate—Rash—Azathioprine—systemic lupus erythematosus	0.000173	0.00219	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000173	0.00219	CcSEcCtD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—ETS1—systemic lupus erythematosus	0.000172	0.00498	CbGpPWpGaD
Bismuth Subsalicylate—Headache—Azathioprine—systemic lupus erythematosus	0.000172	0.00218	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	0.000172	0.00218	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Leflunomide—systemic lupus erythematosus	0.000171	0.00217	CcSEcCtD
Bismuth Subsalicylate—Pain—Cyclosporine—systemic lupus erythematosus	0.000171	0.00217	CcSEcCtD
Bismuth Subsalicylate—Constipation—Cyclosporine—systemic lupus erythematosus	0.000171	0.00217	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—F2—systemic lupus erythematosus	0.00017	0.00492	CbGpPWpGaD
Bismuth Subsalicylate—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.00017	0.00215	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Hydrocortisone—systemic lupus erythematosus	0.00017	0.00215	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	0.000169	0.00488	CbGpPWpGaD
Bismuth Subsalicylate—Confusional state—Methylprednisolone—systemic lupus erythematosus	0.000168	0.00213	CcSEcCtD
Bismuth Subsalicylate—Oedema—Triamcinolone—systemic lupus erythematosus	0.000167	0.00212	CcSEcCtD
Bismuth Subsalicylate—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000167	0.00212	CcSEcCtD
Bismuth Subsalicylate—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000167	0.00212	CcSEcCtD
Bismuth Subsalicylate—Infection—Triamcinolone—systemic lupus erythematosus	0.000166	0.00211	CcSEcCtD
Bismuth Subsalicylate—Infection—Methylprednisolone—systemic lupus erythematosus	0.000166	0.0021	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.000165	0.00209	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Leflunomide—systemic lupus erythematosus	0.000165	0.00209	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Methotrexate—systemic lupus erythematosus	0.000164	0.00207	CcSEcCtD
Bismuth Subsalicylate—Rash—Leflunomide—systemic lupus erythematosus	0.000163	0.00207	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000163	0.00207	CcSEcCtD
Bismuth Subsalicylate—Nausea—Azathioprine—systemic lupus erythematosus	0.000163	0.00207	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000163	0.0047	CbGpPWpGaD
Bismuth Subsalicylate—Headache—Leflunomide—systemic lupus erythematosus	0.000162	0.00206	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic lupus erythematosus	0.000162	0.00469	CbGpPWpGaD
Bismuth Subsalicylate—Erythema—Prednisone—systemic lupus erythematosus	0.000162	0.00205	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000161	0.00204	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000159	0.00201	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000158	0.002	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—systemic lupus erythematosus	0.000158	0.00456	CbGpPWpGaD
Bismuth Subsalicylate—ALB—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000157	0.00452	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000157	0.00198	CcSEcCtD
Bismuth Subsalicylate—PTGS2—S1P1 pathway—VEGFA—systemic lupus erythematosus	0.000156	0.00452	CbGpPWpGaD
Bismuth Subsalicylate—Pain—Prednisolone—systemic lupus erythematosus	0.000156	0.00197	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000156	0.00197	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000155	0.00197	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000155	0.00196	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000154	0.00196	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Biological oxidations—NAT2—systemic lupus erythematosus	0.000154	0.00445	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Leflunomide—systemic lupus erythematosus	0.000154	0.00195	CcSEcCtD
Bismuth Subsalicylate—Pain—Hydrocortisone—systemic lupus erythematosus	0.000152	0.00193	CcSEcCtD
Bismuth Subsalicylate—Oedema—Dexamethasone—systemic lupus erythematosus	0.000152	0.00193	CcSEcCtD
Bismuth Subsalicylate—Oedema—Betamethasone—systemic lupus erythematosus	0.000152	0.00193	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—systemic lupus erythematosus	0.000151	0.00436	CbGpPWpGaD
Bismuth Subsalicylate—Infection—Dexamethasone—systemic lupus erythematosus	0.000151	0.00191	CcSEcCtD
Bismuth Subsalicylate—Infection—Betamethasone—systemic lupus erythematosus	0.000151	0.00191	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.00015	0.0019	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—systemic lupus erythematosus	0.000148	0.00426	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000147	0.00187	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Methotrexate—systemic lupus erythematosus	0.000147	0.00186	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000147	0.00186	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000147	0.00186	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Methotrexate—systemic lupus erythematosus	0.000145	0.00184	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Betamethasone—systemic lupus erythematosus	0.000145	0.00184	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000145	0.00184	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—systemic lupus erythematosus	0.000145	0.00418	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Prednisolone—systemic lupus erythematosus	0.000145	0.00183	CcSEcCtD
Bismuth Subsalicylate—Pain—Triamcinolone—systemic lupus erythematosus	0.000143	0.00181	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—IFNA1—systemic lupus erythematosus	0.000143	0.00413	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000142	0.00179	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—ALB—systemic lupus erythematosus	0.000142	0.00409	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000141	0.00179	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000141	0.00178	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—RASGRP1—systemic lupus erythematosus	0.000139	0.00402	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000138	0.00175	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000138	0.00175	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000138	0.00174	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000137	0.00173	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	0.000136	0.00393	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	0.000136	0.00393	CbGpPWpGaD
Bismuth Subsalicylate—Erythema—Methotrexate—systemic lupus erythematosus	0.000136	0.00172	CcSEcCtD
Bismuth Subsalicylate—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—systemic lupus erythematosus	0.000135	0.00389	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	0.000134	0.00387	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000134	0.00169	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000134	0.00169	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000134	0.00169	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000133	0.00169	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000133	0.00168	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Methotrexate—systemic lupus erythematosus	0.000133	0.00168	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000132	0.00168	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000132	0.00168	CcSEcCtD
Bismuth Subsalicylate—Oedema—Prednisone—systemic lupus erythematosus	0.000132	0.00168	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—FCGR2A—systemic lupus erythematosus	0.000132	0.00382	CbGpPWpGaD
Bismuth Subsalicylate—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000132	0.00167	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000132	0.00167	CcSEcCtD
Bismuth Subsalicylate—Infection—Prednisone—systemic lupus erythematosus	0.000131	0.00167	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—systemic lupus erythematosus	0.000131	0.00379	CbGpPWpGaD
Bismuth Subsalicylate—Pain—Dexamethasone—systemic lupus erythematosus	0.00013	0.00165	CcSEcCtD
Bismuth Subsalicylate—Pain—Betamethasone—systemic lupus erythematosus	0.00013	0.00165	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000129	0.00164	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	0.000129	0.00372	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000127	0.00161	CcSEcCtD
Bismuth Subsalicylate—Rash—Cyclosporine—systemic lupus erythematosus	0.000126	0.0016	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Prednisone—systemic lupus erythematosus	0.000126	0.0016	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000126	0.0016	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000126	0.00159	CcSEcCtD
Bismuth Subsalicylate—Headache—Cyclosporine—systemic lupus erythematosus	0.000125	0.00159	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000125	0.00159	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000125	0.00159	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000124	0.00157	CcSEcCtD
Bismuth Subsalicylate—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000123	0.00156	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000123	0.00156	CcSEcCtD
Bismuth Subsalicylate—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000122	0.00155	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000122	0.00154	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Betamethasone—systemic lupus erythematosus	0.000121	0.00153	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000121	0.00153	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Prednisolone—systemic lupus erythematosus	0.00012	0.00153	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.00012	0.00152	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.00012	0.00152	CcSEcCtD
Bismuth Subsalicylate—Nausea—Cyclosporine—systemic lupus erythematosus	0.000119	0.00151	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000118	0.0015	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000118	0.0015	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000118	0.00149	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000116	0.00148	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—systemic lupus erythematosus	0.000116	0.00336	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000116	0.00147	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	0.000115	0.00333	CbGpPWpGaD
Bismuth Subsalicylate—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000115	0.00146	CcSEcCtD
Bismuth Subsalicylate—Rash—Prednisolone—systemic lupus erythematosus	0.000115	0.00145	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	0.000115	0.00331	CbGpPWpGaD
Bismuth Subsalicylate—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000115	0.00145	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000114	0.00145	CcSEcCtD
Bismuth Subsalicylate—Headache—Prednisolone—systemic lupus erythematosus	0.000114	0.00145	CcSEcCtD
Bismuth Subsalicylate—Constipation—Prednisone—systemic lupus erythematosus	0.000113	0.00143	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000113	0.00143	CcSEcCtD
Bismuth Subsalicylate—ALB—FOXA2 and FOXA3 transcription factor networks—F2—systemic lupus erythematosus	0.000113	0.00326	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—GADD45A—systemic lupus erythematosus	0.000112	0.00324	CbGpPWpGaD
Bismuth Subsalicylate—Rash—Hydrocortisone—systemic lupus erythematosus	0.000112	0.00142	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000112	0.00142	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Methotrexate—systemic lupus erythematosus	0.000112	0.00141	CcSEcCtD
Bismuth Subsalicylate—Headache—Hydrocortisone—systemic lupus erythematosus	0.000111	0.00141	CcSEcCtD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	0.000111	0.00321	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000111	0.0014	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.00011	0.0014	CcSEcCtD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	0.00011	0.00319	CbGpPWpGaD
Bismuth Subsalicylate—Infection—Methotrexate—systemic lupus erythematosus	0.00011	0.00139	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	0.000109	0.00316	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000109	0.00138	CcSEcCtD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—CRP—systemic lupus erythematosus	0.000109	0.00314	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	0.000108	0.00312	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Prednisolone—systemic lupus erythematosus	0.000108	0.00137	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—JAK1—systemic lupus erythematosus	0.000108	0.00312	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000108	0.00136	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Betamethasone—systemic lupus erythematosus	0.000108	0.00136	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000106	0.00135	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000106	0.00135	CcSEcCtD
Bismuth Subsalicylate—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000106	0.00134	CcSEcCtD
Bismuth Subsalicylate—Rash—Triamcinolone—systemic lupus erythematosus	0.000106	0.00134	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000105	0.00134	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Methotrexate—systemic lupus erythematosus	0.000105	0.00134	CcSEcCtD
Bismuth Subsalicylate—Rash—Methylprednisolone—systemic lupus erythematosus	0.000105	0.00133	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000105	0.00133	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Prednisone—systemic lupus erythematosus	0.000105	0.00133	CcSEcCtD
Bismuth Subsalicylate—Headache—Triamcinolone—systemic lupus erythematosus	0.000105	0.00133	CcSEcCtD
Bismuth Subsalicylate—Headache—Methylprednisolone—systemic lupus erythematosus	0.000105	0.00133	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000105	0.00133	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000104	0.00132	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000104	0.00132	CcSEcCtD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL4—systemic lupus erythematosus	0.000102	0.00296	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—F2—systemic lupus erythematosus	0.000101	0.00292	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—IL2RA—systemic lupus erythematosus	0.000101	0.00291	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Dexamethasone—systemic lupus erythematosus	0.0001	0.00127	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Betamethasone—systemic lupus erythematosus	0.0001	0.00127	CcSEcCtD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—F2—systemic lupus erythematosus	0.0001	0.0029	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Triamcinolone—systemic lupus erythematosus	9.95e-05	0.00126	CcSEcCtD
Bismuth Subsalicylate—Nausea—Methylprednisolone—systemic lupus erythematosus	9.92e-05	0.00126	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Methotrexate—systemic lupus erythematosus	9.83e-05	0.00125	CcSEcCtD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	9.75e-05	0.00282	CbGpPWpGaD
Bismuth Subsalicylate—Dyspepsia—Methotrexate—systemic lupus erythematosus	9.73e-05	0.00123	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Betamethasone—systemic lupus erythematosus	9.66e-05	0.00122	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Dexamethasone—systemic lupus erythematosus	9.66e-05	0.00122	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Methotrexate—systemic lupus erythematosus	9.61e-05	0.00122	CcSEcCtD
Bismuth Subsalicylate—Rash—Betamethasone—systemic lupus erythematosus	9.58e-05	0.00121	CcSEcCtD
Bismuth Subsalicylate—Rash—Dexamethasone—systemic lupus erythematosus	9.58e-05	0.00121	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Dexamethasone—systemic lupus erythematosus	9.57e-05	0.00121	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Betamethasone—systemic lupus erythematosus	9.57e-05	0.00121	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—systemic lupus erythematosus	9.55e-05	0.00276	CbGpPWpGaD
Bismuth Subsalicylate—Headache—Betamethasone—systemic lupus erythematosus	9.52e-05	0.00121	CcSEcCtD
Bismuth Subsalicylate—Headache—Dexamethasone—systemic lupus erythematosus	9.52e-05	0.00121	CcSEcCtD
Bismuth Subsalicylate—Pain—Methotrexate—systemic lupus erythematosus	9.46e-05	0.0012	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Prednisone—systemic lupus erythematosus	9.36e-05	0.00119	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	9.27e-05	0.00268	CbGpPWpGaD
Bismuth Subsalicylate—Feeling abnormal—Methotrexate—systemic lupus erythematosus	9.11e-05	0.00115	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Prednisone—systemic lupus erythematosus	9.05e-05	0.00115	CcSEcCtD
Bismuth Subsalicylate—Nausea—Betamethasone—systemic lupus erythematosus	9.03e-05	0.00114	CcSEcCtD
Bismuth Subsalicylate—Nausea—Dexamethasone—systemic lupus erythematosus	9.03e-05	0.00114	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	9e-05	0.0026	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	8.95e-05	0.00258	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—CCL2—systemic lupus erythematosus	8.94e-05	0.00258	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	8.91e-05	0.00257	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—CRP—systemic lupus erythematosus	8.85e-05	0.00255	CbGpPWpGaD
Bismuth Subsalicylate—Urticaria—Methotrexate—systemic lupus erythematosus	8.79e-05	0.00111	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—F2—systemic lupus erythematosus	8.78e-05	0.00254	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Prednisone—systemic lupus erythematosus	8.75e-05	0.00111	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Methotrexate—systemic lupus erythematosus	8.74e-05	0.00111	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	8.69e-05	0.00251	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Biological oxidations—RXRA—systemic lupus erythematosus	8.64e-05	0.0025	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	8.55e-05	0.00247	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—systemic lupus erythematosus	8.49e-05	0.00245	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Prednisone—systemic lupus erythematosus	8.41e-05	0.00107	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	8.39e-05	0.00242	CbGpPWpGaD
Bismuth Subsalicylate—Rash—Prednisone—systemic lupus erythematosus	8.34e-05	0.00106	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Prednisone—systemic lupus erythematosus	8.34e-05	0.00106	CcSEcCtD
Bismuth Subsalicylate—Headache—Prednisone—systemic lupus erythematosus	8.29e-05	0.00105	CcSEcCtD
Bismuth Subsalicylate—ALB—Folate Metabolism—F2—systemic lupus erythematosus	8.16e-05	0.00236	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	8.14e-05	0.00235	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—CLU—systemic lupus erythematosus	8.1e-05	0.00234	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—F2—systemic lupus erythematosus	8.02e-05	0.00231	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	7.96e-05	0.0023	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL4—systemic lupus erythematosus	7.95e-05	0.0023	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Prednisone—systemic lupus erythematosus	7.86e-05	0.000996	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—P2RY12—systemic lupus erythematosus	7.85e-05	0.00227	CbGpPWpGaD
Bismuth Subsalicylate—Pruritus—Methotrexate—systemic lupus erythematosus	7.82e-05	0.000991	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	7.71e-05	0.00223	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	7.65e-05	0.00221	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	7.63e-05	0.0022	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—IFNG—systemic lupus erythematosus	7.6e-05	0.0022	CbGpPWpGaD
Bismuth Subsalicylate—Diarrhoea—Methotrexate—systemic lupus erythematosus	7.57e-05	0.000959	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	7.34e-05	0.00212	CbGpPWpGaD
Bismuth Subsalicylate—Dizziness—Methotrexate—systemic lupus erythematosus	7.31e-05	0.000927	CcSEcCtD
Bismuth Subsalicylate—TF—Hemostasis—ALB—systemic lupus erythematosus	7.3e-05	0.00211	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—CCL2—systemic lupus erythematosus	7.28e-05	0.0021	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—CSK—systemic lupus erythematosus	7.22e-05	0.00209	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	7.2e-05	0.00208	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	7.15e-05	0.00206	CbGpPWpGaD
Bismuth Subsalicylate—Vomiting—Methotrexate—systemic lupus erythematosus	7.03e-05	0.000891	CcSEcCtD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	7.03e-05	0.00203	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—NOS3—systemic lupus erythematosus	6.98e-05	0.00202	CbGpPWpGaD
Bismuth Subsalicylate—Rash—Methotrexate—systemic lupus erythematosus	6.97e-05	0.000884	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Methotrexate—systemic lupus erythematosus	6.97e-05	0.000883	CcSEcCtD
Bismuth Subsalicylate—Headache—Methotrexate—systemic lupus erythematosus	6.93e-05	0.000878	CcSEcCtD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	6.66e-05	0.00192	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	6.61e-05	0.00191	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TLR4—systemic lupus erythematosus	6.59e-05	0.0019	CbGpPWpGaD
Bismuth Subsalicylate—Nausea—Methotrexate—systemic lupus erythematosus	6.57e-05	0.000832	CcSEcCtD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—LYN—systemic lupus erythematosus	6.56e-05	0.00189	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—F2—systemic lupus erythematosus	6.49e-05	0.00187	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	6.32e-05	0.00182	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	6.31e-05	0.00182	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IFNG—systemic lupus erythematosus	6.19e-05	0.00179	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—systemic lupus erythematosus	6.18e-05	0.00178	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—CD4—systemic lupus erythematosus	6.09e-05	0.00176	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	6.08e-05	0.00175	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—IL2—systemic lupus erythematosus	5.92e-05	0.00171	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	5.78e-05	0.00167	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—CDKN1B—systemic lupus erythematosus	5.73e-05	0.00165	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—CCL2—systemic lupus erythematosus	5.65e-05	0.00163	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL2—systemic lupus erythematosus	5.5e-05	0.00159	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—EP300—systemic lupus erythematosus	5.31e-05	0.00153	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—CDKN1A—systemic lupus erythematosus	5.28e-05	0.00153	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	5.17e-05	0.00149	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—EP300—systemic lupus erythematosus	5.03e-05	0.00145	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—VEGFA—systemic lupus erythematosus	5.03e-05	0.00145	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	4.98e-05	0.00144	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	4.95e-05	0.00143	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—RASGRP1—systemic lupus erythematosus	4.92e-05	0.00142	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—TNF—systemic lupus erythematosus	4.92e-05	0.00142	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	4.92e-05	0.00142	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IFNG—systemic lupus erythematosus	4.8e-05	0.00139	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	4.71e-05	0.00136	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—ITGAX—systemic lupus erythematosus	4.69e-05	0.00135	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—F3—systemic lupus erythematosus	4.62e-05	0.00133	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TGFB1—systemic lupus erythematosus	4.61e-05	0.00133	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	4.36e-05	0.00126	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL2—systemic lupus erythematosus	4.27e-05	0.00123	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CLU—systemic lupus erythematosus	4.18e-05	0.00121	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—P2RY12—systemic lupus erythematosus	4.04e-05	0.00117	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MMP9—systemic lupus erythematosus	4.04e-05	0.00117	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—VEGFA—systemic lupus erythematosus	4.01e-05	0.00116	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TNF—systemic lupus erythematosus	4e-05	0.00116	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	4e-05	0.00115	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—IL6—systemic lupus erythematosus	3.97e-05	0.00115	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	3.93e-05	0.00114	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—JAK1—systemic lupus erythematosus	3.82e-05	0.0011	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—systemic lupus erythematosus	3.82e-05	0.0011	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SELE—systemic lupus erythematosus	3.72e-05	0.00107	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CSK—systemic lupus erythematosus	3.72e-05	0.00107	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—TGFB1—systemic lupus erythematosus	3.68e-05	0.00106	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—IL2RA—systemic lupus erythematosus	3.57e-05	0.00103	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic lupus erythematosus	3.5e-05	0.00101	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—ITGAM—systemic lupus erythematosus	3.5e-05	0.00101	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—LYN—systemic lupus erythematosus	3.38e-05	0.000977	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	3.33e-05	0.000962	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.32e-05	0.000958	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SH2B3—systemic lupus erythematosus	3.32e-05	0.000958	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL6—systemic lupus erythematosus	3.23e-05	0.000933	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	3.18e-05	0.000919	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	3.17e-05	0.000916	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TNF—systemic lupus erythematosus	3.11e-05	0.000898	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—F2—systemic lupus erythematosus	3.1e-05	0.000897	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—XRCC6—systemic lupus erythematosus	3.1e-05	0.000895	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	2.97e-05	0.000857	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	2.74e-05	0.000791	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	2.64e-05	0.000761	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.63e-05	0.000761	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IFNA1—systemic lupus erythematosus	2.61e-05	0.000753	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	2.61e-05	0.000753	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	2.57e-05	0.000741	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—RASGRP1—systemic lupus erythematosus	2.54e-05	0.000733	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	2.51e-05	0.000725	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	2.47e-05	0.000713	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	2.29e-05	0.00066	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	2.27e-05	0.000654	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CSK—systemic lupus erythematosus	2.23e-05	0.000643	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.13e-05	0.000615	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	2.12e-05	0.000611	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.1e-05	0.000605	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CD247—systemic lupus erythematosus	2.09e-05	0.000605	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	2.09e-05	0.000604	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	2.09e-05	0.000604	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NCF2—systemic lupus erythematosus	2.04e-05	0.000588	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.03e-05	0.000585	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—JAK1—systemic lupus erythematosus	1.97e-05	0.000568	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.88e-05	0.000544	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IL2RA—systemic lupus erythematosus	1.84e-05	0.000531	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	1.78e-05	0.000513	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NAT2—systemic lupus erythematosus	1.69e-05	0.000489	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.66e-05	0.00048	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.65e-05	0.000476	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	1.63e-05	0.000471	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—F2—systemic lupus erythematosus	1.6e-05	0.000462	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—JUNB—systemic lupus erythematosus	1.6e-05	0.000462	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.5e-05	0.000432	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	1.48e-05	0.000427	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PRL—systemic lupus erythematosus	1.47e-05	0.000425	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.37e-05	0.000396	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.35e-05	0.000389	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS3—systemic lupus erythematosus	1.27e-05	0.000367	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—JAK1—systemic lupus erythematosus	1.18e-05	0.00034	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	1.17e-05	0.000339	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CCR5—systemic lupus erythematosus	1.12e-05	0.000322	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.09e-05	0.000314	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IL2—systemic lupus erythematosus	1.08e-05	0.000311	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.06e-05	0.000306	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—EP300—systemic lupus erythematosus	9.67e-06	0.000279	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—RXRA—systemic lupus erythematosus	9.49e-06	0.000274	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	9.33e-06	0.000269	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CD80—systemic lupus erythematosus	9.18e-06	0.000265	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—VEGFA—systemic lupus erythematosus	9.16e-06	0.000264	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	8.8e-06	0.000254	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TGFB1—systemic lupus erythematosus	8.41e-06	0.000243	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALB—systemic lupus erythematosus	8.39e-06	0.000242	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	8.03e-06	0.000232	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TYK2—systemic lupus erythematosus	7.75e-06	0.000224	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS3—systemic lupus erythematosus	7.61e-06	0.00022	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	7.41e-06	0.000214	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	7.34e-06	0.000212	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CD4—systemic lupus erythematosus	7.01e-06	0.000202	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALB—systemic lupus erythematosus	6.66e-06	0.000192	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	6.59e-06	0.00019	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	6.37e-06	0.000184	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—EP300—systemic lupus erythematosus	6.11e-06	0.000176	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	6.08e-06	0.000176	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPARG—systemic lupus erythematosus	5.99e-06	0.000173	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—EP300—systemic lupus erythematosus	5.79e-06	0.000167	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NOS3—systemic lupus erythematosus	5.15e-06	0.000149	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TGFB1—systemic lupus erythematosus	5.03e-06	0.000145	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—EP300—systemic lupus erythematosus	4.85e-06	0.00014	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTGS2—systemic lupus erythematosus	4.71e-06	0.000136	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—EP300—systemic lupus erythematosus	3.92e-06	0.000113	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6—systemic lupus erythematosus	3.79e-06	0.000109	CbGpPWpGaD
